Citation
Peery, Harry E., et al. "Anti-NMDA Receptor Encephalitis. the Disorder, the Diagnosis and the Immunobiology." Autoimmunity Reviews, vol. 11, no. 12, 2012, pp. 863-72.
Peery HE, Day GS, Dunn S, et al. Anti-NMDA receptor encephalitis. The disorder, the diagnosis and the immunobiology. Autoimmun Rev. 2012;11(12):863-72.
Peery, H. E., Day, G. S., Dunn, S., Fritzler, M. J., Prüss, H., De Souza, C., Doja, A., Mossman, K., Resch, L., Xia, C., Sakic, B., Belbeck, L., & Foster, W. G. (2012). Anti-NMDA receptor encephalitis. The disorder, the diagnosis and the immunobiology. Autoimmunity Reviews, 11(12), 863-72. https://doi.org/10.1016/j.autrev.2012.03.001
Peery HE, et al. Anti-NMDA Receptor Encephalitis. the Disorder, the Diagnosis and the Immunobiology. Autoimmun Rev. 2012;11(12):863-72. PubMed PMID: 22440397.
TY - JOUR
T1 - Anti-NMDA receptor encephalitis. The disorder, the diagnosis and the immunobiology.
AU - Peery,Harry E,
AU - Day,Gregory S,
AU - Dunn,Shannon,
AU - Fritzler,Marvin J,
AU - Prüss,Harald,
AU - De Souza,Claire,
AU - Doja,Asif,
AU - Mossman,Karen,
AU - Resch,Lothar,
AU - Xia,Chenjie,
AU - Sakic,Boris,
AU - Belbeck,Larry,
AU - Foster,Warren G,
Y1 - 2012/03/11/
PY - 2012/03/01/received
PY - 2012/03/07/accepted
PY - 2012/3/24/entrez
PY - 2012/3/24/pubmed
PY - 2013/2/7/medline
SP - 863
EP - 72
JF - Autoimmunity reviews
JO - Autoimmun Rev
VL - 11
IS - 12
N2 - Anti-NMDAR encephalitis is a newly characterized syndrome with a progressive, predictable clinical course and the possibility of effective treatment. Accurate and timely diagnosis is critical to selection and implementation of treatments, and optimal patient outcomes. Outcomes are improved with early diagnosis via indirect immunofluorescence or cell-based assays, and the rapid and appropriate administration of immunosuppressant and anti-psychotic therapies. Three possible scenarios accounting for the immunopathogenesis of anti-NMDAR encephalitis are presented, with the most probable one being that of paraneoplastic autoimmunity. Future efforts in this disorder should focus on elucidating the mechanisms that contribute to initiation of this antibody response, as well as exploring the role of tumors, infectious triggers and immune-reactivation. Finally, accessible tools need to be developed that allow for reliable identification of specific antibody markers against synaptic proteins.
SN - 1873-0183
UR - https://www.unboundmedicine.com/medline/citation/22440397/Anti_NMDA_receptor_encephalitis__The_disorder_the_diagnosis_and_the_immunobiology_
L2 - https://linkinghub.elsevier.com/retrieve/pii/S1568-9972(12)00061-4
DB - PRIME
DP - Unbound Medicine
ER -